Bayer Pharmaceuticals accelerates innovations for patients
LifeProNow
MARCH 27, 2023
The estimated compounded annual growth rate is more than 26 percent reaching $1.36 Bayer works on leveraging all the possibilities of the technologies while fully integrating all regulatory and bioethical requirements.” Bayer has exclusive worldwide marketing rights for this product including the U.S. billion in sales by 2026.
130 
Let's personalize your content